Bain Capital Life Sciences Fund IV, L.P. — insider trades

Stock trades Bain Capital Life Sciences Fund IV, L.P. reported on SEC Form 4 at KLRA Kailera Therapeutics, Inc., OLMA Olema Pharmaceuticals, Inc..

• Apr 20, 2026: bought 1,562,500 shares of KLRA Kailera Therapeutics, Inc. ($25.0M)
• Jan 8, 2025: bought 300,000 shares of OLMA Olema Pharmaceuticals, Inc. ($1.73M)